Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Primary osteoarthritis of knee (confirmed by American College of Rheumatology \[ACR\] criteria).~* Requirement of regular non-steroidal anti-inflammatory drug (NSAID) therapy.~Exclusion Criteria:~* Evidence of active gastrointestinal ulceration within 12 months prior to the screening visit or history of active gastrointestinal bleeding within the previous 5 years.~* Known hypersensitivity to analgesics, antipyretics, or NSAIDS (including celecoxib).~Other protocol-defined inclusion/exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).